Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epithelial to Mesenchymal Transition: A Mechanism that Fuels Cancer Radio/Chemoresistance
József Dudás, Andrea Ladányi, Julia Ingruber, et al.
Cells (2020) Vol. 9, Iss. 2, pp. 428-428
Open Access | Times Cited: 164

Showing 1-25 of 164 citing articles:

Dynamic EMT: a multi‐tool for tumor progression
Simone Brabletz, Harald Schuhwerk, Thomas Brabletz, et al.
The EMBO Journal (2021) Vol. 40, Iss. 18
Open Access | Times Cited: 506
The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis
Yuhe Huang, Weiqi Hong, Xiawei Wei
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 490
Targeting macrophages in cancer immunotherapy
Zhaojun Duan, Yunping Luo
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 470
Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance
Nuray Erin, Jelena Grahovac, Anamaria Brozović, et al.
Drug Resistance Updates (2020) Vol. 53, pp. 100715-100715
Open Access | Times Cited: 389
Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies
Nisha Kumari, Seung Hong Choi
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 217
CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer
María Auxiliadora Olivares‐Urbano, Carmen Griñán‐Lisón, Juan Antonio Marchal, et al.
Cells (2020) Vol. 9, Iss. 7, pp. 1651-1651
Open Access | Times Cited: 177
Pericytes in the tumor microenvironment
Zhongyi Jiang, Jing Zhou, Luohong Li, et al.
Cancer Letters (2023) Vol. 556, pp. 216074-216074
Open Access | Times Cited: 72
miRNAs role in bladder cancer pathogenesis and targeted therapy: Signaling pathways interplay – A review
Hesham A. El-Mahdy, Elsayed G.E. Elsakka, Ahmed A. El-Husseiny, et al.
Pathology - Research and Practice (2023) Vol. 242, pp. 154316-154316
Closed Access | Times Cited: 59
The interplay of signaling pathways and miRNAs in the pathogenesis and targeted therapy of esophageal cancer
Ahmed S. Doghish, Ahmed A. El-Husseiny, Nourhan M. Abdelmaksoud, et al.
Pathology - Research and Practice (2023) Vol. 246, pp. 154529-154529
Closed Access | Times Cited: 45
A gene regulatory network to control EMT programs in development and disease
Hassan Fazilaty, Luciano Rago, Khalil Kass Youssef, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 109
MiR-155 Inhibitor-Laden Exosomes Reverse Resistance to Cisplatin in a 3D Tumor Spheroid and Xenograft Model of Oral Cancer
Adil Ali Sayyed, Piyush Gondaliya, Mukund Mali, et al.
Molecular Pharmaceutics (2021) Vol. 18, Iss. 8, pp. 3010-3025
Closed Access | Times Cited: 65
The role of macrophages in the tumor microenvironment and tumor metabolism
Pritam Sadhukhan, Tanguy Y. Seiwert
Seminars in Immunopathology (2023) Vol. 45, Iss. 2, pp. 187-201
Closed Access | Times Cited: 27
Regulation of T cells by myeloid-derived suppressor cells: emerging immunosuppressor in lung cancer
Zhongning He, Chunyu Zhang, Yuwei Zhao, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 24
Exploiting transcription factors to target EMT and cancer stem cells for tumor modulation and therapy
Abdul Quaiyoom Khan, Adria Hasan, Snober S. Mir, et al.
Seminars in Cancer Biology (2024) Vol. 100, pp. 1-16
Closed Access | Times Cited: 14
Global research trends and emerging hotspots in nano-drug delivery systems for lung cancer: a comprehensive bibliometric analysis (1998–2024)
Yu Cao, Chunhai Fan, Y. Chen, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Fusobacterium nucleatum Accelerates the Progression of Colitis-Associated Colorectal Cancer by Promoting EMT
Mi Ra Yu, Hye Jung Kim, Hae Ryoun Park
Cancers (2020) Vol. 12, Iss. 10, pp. 2728-2728
Open Access | Times Cited: 63
SPP1 Promotes Enzalutamide Resistance and Epithelial‐Mesenchymal‐Transition Activation in Castration‐Resistant Prostate Cancer via PI3K/AKT and ERK1/2 Pathways
Xiaocong Pang, Junling Zhang, He Xu, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 55
Photodynamic therapy regulates fate of cancer stem cells through reactive oxygen species
Zijian Zhang, Kunpeng Wang, Jinggang Mo, et al.
World Journal of Stem Cells (2020) Vol. 12, Iss. 7, pp. 562-584
Open Access | Times Cited: 51
Nanomaterials and hepatic disease: toxicokinetics, disease types, intrinsic mechanisms, liver susceptibility, and influencing factors
Ting Sun, Yiyuan Kang, Jia Liu, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 46
Focus on immune checkpoint PD-1/PD-L1 pathway: New advances of polyphenol phytochemicals in tumor immunotherapy
Kunjing Liu, Qi Sun, Qi Liu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113618-113618
Open Access | Times Cited: 34
Cancer-educated mammary adipose tissue-derived stromal/stem cells in obesity and breast cancer: spatial regulation and function
Andreas Ritter, Nina‐Naomi Kreis, Susanne Roth, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 20
Loss of p53 epigenetically modulates epithelial to mesenchymal transition in colorectal cancer
Shreya Sharma, Harsha Rani, Yeshwanth Mahesh, et al.
Translational Oncology (2024) Vol. 43, pp. 101848-101848
Open Access | Times Cited: 7
The role of tissue-resident memory T cells as mediators for response and toxicity in immunotherapy-treated melanoma—two sides of the same coin?
Robin Reschke, Benjamin Deitert, Alex H. Enk, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
The Role of TAMs in the Regulation of Tumor Cell Resistance to Chemotherapy
Ryan McWhorter, Benjamin Bonavida
Critical Reviews™ in Oncogenesis (2024) Vol. 29, Iss. 4, pp. 97-125
Closed Access | Times Cited: 6
Roles of S100 family members in drug resistance in tumors: Status and prospects
Xin Hua, Hongming Zhang, Jinfang Jia, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 127, pp. 110156-110156
Open Access | Times Cited: 47
Page 1 - Next Page

Scroll to top